Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Sep 30;12(10):3002.
doi: 10.3390/nu12103002.

A Low FODMAP Diet Is Nutritionally Adequate and Therapeutically Efficacious in Community Dwelling Older Adults with Chronic Diarrhoea

Affiliations
Observational Study

A Low FODMAP Diet Is Nutritionally Adequate and Therapeutically Efficacious in Community Dwelling Older Adults with Chronic Diarrhoea

Leigh O'Brien et al. Nutrients. .

Abstract

The low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP)diet has been extensively researched, but not in the management of older adults with functional gastrointestinal symptoms. This study determines the positive and negative impacts of this dietary treatment in older adults with chronic diarrhea. A non-blinded intervention study was conducted with adults over 65 years with chronic diarrhea referred for colonoscopy where no cause was found. Participants followed a dietitian-led low FODMAP diet for six weeks and completed a structured assessment of gastrointestinal symptoms, the Hospital Anxiety and Depression scale, and a four-day food diary before and after the intervention. Twenty participants, mean age 76 years, were recruited. Adherence to the low FODMAP diet was acceptable; mean daily FODMAP intake reduced from 20.82 g to 3.75 g (p < 0.001) during the intervention and no clinically significant changes in macro- or micronutrient intakes were observed. There were clinically significant improvements in total gastrointestinal symptoms (pre diet 21.15/88 (standard deviation SD = 10.99), post diet 9.8/88 (SD = 9.58), p < 0.001) including diarrhea (pre diet 9.85 (SD = 3.84), post diet 4.05 (SD = 3.86), p < 0.001) and significant reductions in anxiety (pre diet 6.11/21 (SD = 4.31), post diet 4.26/21 (SD = 3.38), p < 0.05). In older adults the low FODMAP diet is clinically effective and does not jeopardise nutritional intake when supervised by an experienced dietitian.

Keywords: diet; fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet; food; gastrointestinal diseases; nutrition; older adults; quality of life; therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram of participant recruitment. FODMAP: fermentable oligosaccharides, disaccharides, monosaccharides, and polyols.
Figure 2
Figure 2
Individual gastrointestinal symptom improvement (Total Structured Assessment of Gastrointestinal Symptoms (SAGIS) scores) from baseline to follow-up. Mean difference from the pre intervention to follow-up scores was 11.35 with a standard deviation of 10.75 p < 0.001.
Figure 3
Figure 3
Individual diarrhea improvement scores from baseline to follow-up. Mean difference from the pre intervention to follow-up scores of 5.8 with a standard deviation of 4.48 p < 0.001.

References

    1. Minocha A., Johnson W.D., Abell T.L., Wigington W.C. Prevalence, Sociodemography, and QualitLife of Older Versus Younger Patients with Irritable Bowel Syndrome: A Population-Based Study. Dig. Dis. Sci. 2006;51:446–453. doi: 10.1007/s10620-006-3153-8. - DOI - PubMed
    1. Chang L. Review article: Epidemiology and quality of life in functional gastrointestinal disorders. Aliment. Pharmacol. Ther. 2004;20:31–39. doi: 10.1111/j.1365-2036.2004.02183.x. - DOI - PubMed
    1. Holtmann G.J., Ford A.C., Talley N.J. Pathophysiology of irritable bowel syndrome. Lancet Gastroenterol. Hepatol. 2016;1:133–146. doi: 10.1016/S2468-1253(16)30023-1. - DOI - PubMed
    1. Card T., Canavan C., West J. The epidemiology of irritable bowel syndrome. Clin. Epidemiol. 2014;6:71–80. doi: 10.2147/CLEP.S40245. - DOI - PMC - PubMed
    1. Schmulson M.J., Drossman D.A. What Is New in Rome IV. J. Neurogastroenterol. Motil. 2017;23:151–163. doi: 10.5056/jnm16214. - DOI - PMC - PubMed

Publication types